GLP1R and cardiac hypertrophy: Although our in vitro qRT-PCR experiments confirmed that GLP-1 receptor agonists attenuate myocardial hypertrophy, which correlates with downregulation of miR-27a and upregulation of CSE/H2S, this does not establish a direct causal regulatory relationship.